Evidence map›Paper›PMID 37109365›Full record

ArticleJournal of clinical medicine2023

Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction.

Lourdes Vicent, Jesús Álvarez-García, Rafael Vazquez-Garcia, José R González-Juanatey, Miguel Rivera, Javier Segovia, Domingo Pascual-Figal, Ramón Bover, Fernando Worner, Francisco Fernández-Avilés and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 11 institutions in 1 country.

Lourdes VicentCardiology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0001-7914-9788
Jesús Álvarez-GarcíaCardiology Department, Hospital de la Santa Creu i Sant Pau, CIBERCV, 08025 Barcelona, Spain.ORCID 0000-0002-2015-6446
Rafael Vazquez-GarciaCardiology Department, Puerta del Mar University Hospital, 11009 Cádiz, Spain.ORCID 0000-0001-8876-474X
José R González-JuanateyCardiology Department, Hospital Clínico Universitario de Santiago, CIBERCV, 15076 Santiago de Compostela, Spain.ORCID 0000-0001-9681-3388
Miguel RiveraCardiology Department, University Hospital La Fe, 46026 Valencia, Spain.
Javier SegoviaCardiology Department, Hospital Universitario Puerta de Hierro Majadahonda, CIBERCV, 28222 Madrid, Spain.ORCID 0000-0002-4606-3416
Domingo Pascual-FigalCardiology Department, Hospital Virgen de la Arrixaca, Department of Medicine, University of Murcia, 30120 Murcia, Spain.ORCID 0000-0002-4993-9540
Ramón BoverCardiology Department, Hospital Clínico San Carlos, 28040 Madrid, Spain.
Fernando WornerServicio de Cardiología, Hospital Universitari Arnau de Vilanova, 25198 Lleida, Spain.
Francisco Fernández-AvilésCardiology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Albert Ariza-SoleCardiology Department, Bellvitge University Hospital General, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.ORCID 0000-0002-0819-6656
Manuel Martínez-SellésCardiology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0003-0289-6229
Centro de Investigación en Red en Enfermedades Cardiovasculares · ESBellvitge University Hospital · ESHospital Clínico San Carlos · ESHospital de Sant Pau · ESHospital General Universitario Gregorio Marañón · ESHospital Universitari Arnau de Vilanova · ESHospital Universitari i Politècnic La Fe · ESHospital Universitario 12 De Octubre · ESHospital Universitario Puerta del Mar · ESSpanish National Centre for Cardiovascular Research · ESUniversidad Complutense de Madrid · ES

Funding

Instituto de Salud Carlos III CM20/00104 and JR22/00004
6 · The paper itself

Abstract

Our aim was to determine the prognostic impact of coronary artery disease (CAD) on heart failure with reduced ejection fraction (HFrEF) mortality and readmissions. From a prospective multicenter registry that included 1831 patients hospitalized due to heart failure, 583 had a left ventricular ejection fraction of <40%. In total, 266 patients (45.6%) had coronary artery disease as main etiology and 137 (23.5%) had idiopathic dilated cardiomyopathy (DCM), and they are the focus of this study. Significant differences were found in Charlson index (CAD 4.4 ± 2.8, idiopathic DCM 2.9 ± 2.4,

Indexed as

coronary artery diseasedilated cardiomyopathyheart failureischemic heart diseasemortalityreadmissions

Identifiers

PMID37109365
PMCPMC10143946
OpenAlexW4366775279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.